Feasibility and Short-Term Outcomes of Percutaneous Transcatheter Pulmonary Valve Replacement in Small (<30 kg) Children With Dysfunctional Right Ventricular Outflow Tract Conduits

Circulation: Cardiovascular Interventions

Volumn 7, Issue 2, 2014, Pages 142-148

  Berman, Darren P ^a   McElhinney, Doff B ^b,c   Vincent, Julie A ^d   Hellenbrand, William E ^d,e   Zahn, Evan M ^a,f  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e YALE UNIVERSITY   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiac Catheterization; Congenital; Heart Defects; Pulmonary Valve

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ARTICLE; BACTERIAL ENDOCARDITIS; CHILD; CLINICAL ARTICLE; FEMALE; FEMORAL VEIN; FOLLOW UP; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; INTERNAL JUGULAR VEIN; MALE; MEDICAL DEVICE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY VALVE PROSTHESIS; PULMONARY VALVE REPLACEMENT; RIGHT VENTRICLE TO PULMONARY ARTERY CONDUIT; SCHOOL CHILD; STENOSIS; SUBCLAVIAN VEIN; TRANSCATHETER PULMONARY VALVE REPLACEMENT; ANGIOCARDIOGRAPHY; BODY SIZE; BODY WEIGHT; CLINICAL TRIAL; EVALUATION STUDY; FEASIBILITY STUDY; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART RIGHT VENTRICLE FUNCTION; HEART VALVE REPLACEMENT; HEMODYNAMICS; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; PROCEDURES; PULMONARY VALVE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; BODY SIZE; BODY WEIGHT; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FEMORAL VEIN; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY VALVE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84900411960     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.000881     Document Type: Article

References (24)

1. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-1405.
2. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, Vincent JA. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507-516.
3. Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, Lock JE, Jones TK. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6:535-542.
4. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, Hellenbrand WE. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011;4:602-614.
5. Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, Lock JE. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a fifteen-year experience. Circulation. 2006;113:2598-2605.
6. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the US Clinical trial. J Am Coll Cardiol. 2009;54:1722-1729.
7. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, Cooper J, Muthurangu V, Hegde SR, Razavi RS, Pellerin D, Deanfield J, Bonhoeffer P. Transcatheter pulmonary valve implantation in humans: initial results in 59 consecutive patients. Circulation. 2005;112:1189-1197.
8. Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, Busch R, Hess J, Berger F. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260-1265.
9. Butera G, Milanesi O, Spadoni I, Piazza L, Donti A, Ricci C, Agnoletti G, Pangrazi A, Chessa M, Carminati M. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013;81:310-316.
10. Vezmar M, Chaturvedi R, Lee KJ, Almeida C, Manlhiot C, McCrindle BW, Horlick EM, Benson LN. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC. 2010;3:439-448.
11. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964-1972.
12. Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg. 1984;32:257-259.
13. Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J. 1992;67:470-473.
14. Eyskens B, Reybrouck T, Bogaert J, Dymarkowsky S, Daenen W, Dumoulin M, Gewillig M. Homograft insertion for pulmonary regurgitation after repair of tetralogy of Fallot improves cardiorespiratory exercise performance. Am J Cardiol. 2000;85:221-225.
15. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981.
16. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, Williams WG, Webb G, Gatzoulis MA. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489-2494.
17. Tweddell JS, Simpson P, Li SH, Dunham-Ingle J, Bartz PJ, Earing MG, Pelech AN. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2012;15:27-33.
18. Lindsey CW, Parks WJ, Kogon BE, Sallee D III, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg. 2010;89:147-151.
19. Batlivala SP, Emani S, Mayer JE, McElhinney DB. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. 2012;93:2007-2016.
20. Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, van Doorn C, Bonhoeffer P, Taylor AM. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation. 2008;118(14 suppl):S182-S190.
21. Holoshitz N, Ilbawi MN, Amin Z. Periventricular Melody valve implantation in a 12 kg child. Catheter Cardiovasc Interv. 2013;82:824-827.
22. Simpson KE, Huddleston CB, Foerster S, Nicholas R, Balzer D. Successful subxyphoid hybrid approach for placement of a Melody percutaneous pulmonary valve. Catheter Cardiovasc Interv. 2011;78:108-111.
23. Carr M, Bergersen L, Marshall AC, Keane JF, Lock JE, Emani SM, McElhinney DB. Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv. 2013;81:E44-E52.
24. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292-300.